Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Urogen Pharma Ltd
(NQ:
URGN
)
12.80
+0.08 (+0.63%)
Streaming Delayed Price
Updated: 10:39 AM EDT, Jun 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Urogen Pharma Ltd
< Previous
1
2
3
4
5
6
Next >
UroGen Pharma Q4 2021 Earnings Conference Call On March 21, 2022 At 10:00 AM ET
March 17, 2022
UroGen Pharma (NASDAQ:URGN) will host a conference call at 10:00 AM ET on March 21, 2022, to discuss Q4 2021 earnings results. How to Attend UroGen Pharma (URGN) Conference Call...
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
Earnings Outlook For UroGen Pharma
March 09, 2022
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
88 Biggest Movers From Yesterday
March 09, 2022
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala...
Via
Benzinga
UroGen Pharma to Participate in Panel Discussion at Cowen 42nd Annual Healthcare Conference
February 28, 2022
From
UroGen Pharma Ltd.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
February 22, 2022
During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...
Via
Benzinga
UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients
February 10, 2022
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Announces Start of Pivotal Single-Arm Phase 3 Trial for UGN-102, an Investigational Non-Surgical Treatment for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
February 03, 2022
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Present at Upcoming Conferences
January 05, 2022
From
UroGen Pharma Ltd.
Via
Business Wire
First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
December 21, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 06, 2022
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...
Via
Benzinga
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
70 Biggest Movers From Yesterday
November 16, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...
Via
Benzinga
UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
November 15, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For November 15, 2021
November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to...
Via
Benzinga
Earnings Preview: UroGen Pharma
November 12, 2021
UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
UroGen Pharma Announces Upcoming 2021 Conferences
November 11, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Unveils New Phase 3 Development Plan for UGN-102 at Spotlight Event
November 10, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Host Virtual Spotlight Event on November 10, 2021
November 01, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
The Journal of Urology Publishes Results of UroGen Pharma’s Phase 2b Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
October 05, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Present at the 2021 Cantor Virtual Global Healthcare Conference
September 23, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Presents Data Showcasing Novel Clinical Data at 2021 American Urological Association (AUA) Annual Meeting
September 13, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 10, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 03, 2021
From
UroGen Pharma Ltd.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
August 20, 2021
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.